Variant report

Variant	nsv1059041
Chromosome Location	chr20:25832105-26007269
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:1259)
CpG islands
(count:672)
Chromatin interactive
region (count:1)
LncRNA
region (count:29)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:1259 , 50 per page) page: 1 2 3 4 5 6 7 ... 26

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr20:25989422-25989527	HepG2	liver:	n/a	n/a
2	ARID3A	chr20:25848512-25848702	K562	blood:	n/a	n/a
3	ATF2	chr20:25990276-25990617	GM12878	blood:	n/a	n/a
4	ATF3	chr20:25843689-25844092	HepG2	liver:	n/a	n/a
5	BACH1	chr20:25848341-25848706	K562	blood:	n/a	n/a
6	BATF	chr20:25914679-25914959	GM12878	blood:	n/a	n/a
7	BATF	chr20:25975707-25975907	GM12878	blood:	n/a	n/a
8	BATF	chr20:25914607-25914931	GM12878	blood:	n/a	n/a
9	BATF	chr20:25991390-25991666	GM12878	blood:	n/a	n/a
10	BCL11A	chr20:25846720-25846953	GM12878	blood:	n/a	n/a
11	BCL11A	chr20:25846694-25846979	GM12878	blood:	n/a	n/a
12	BCL11A	chr20:25843000-25843149	GM12878	blood:	n/a	n/a
13	BCL11A	chr20:25990610-25990918	GM12878	blood:	n/a	n/a
14	BCL3	chr20:25945773-25946163	GM12878	blood:	n/a	n/a
15	BHLHE40	chr20:25975281-25975466	GM12878	blood:	n/a	n/a
16	BHLHE40	chr20:25838692-25838875	K562	blood:	n/a	n/a
17	BHLHE40	chr20:25844497-25844502	K562	blood:	n/a	n/a
18	BHLHE40	chr20:25968676-25968796	K562	blood:	n/a	chr20:25968678-25968699 chr20:25968682-25968695
19	BHLHE40	chr20:25834600-25834731	K562	blood:	n/a	n/a
20	BHLHE40	chr20:25840427-25840668	K562	blood:	n/a	n/a
21	BHLHE40	chr20:25843608-25844126	K562	blood:	n/a	n/a
22	BHLHE40	chr20:25848340-25848714	K562	blood:	n/a	n/a
23	BHLHE40	chr20:25975821-25976057	GM12878	blood:	n/a	n/a
24	BRCA1	chr20:25990237-25990584	HepG2	liver:	n/a	chr20:25990394-25990403
25	BRCA1	chr20:25990247-25990579	GM12878	blood:	n/a	chr20:25990394-25990403
26	BRCA1	chr20:25834562-25834610	HepG2	liver:	n/a	n/a
27	BRCA1	chr20:25848499-25848704	HepG2	liver:	n/a	n/a
28	BRCA1	chr20:25990208-25990605	Hela-S3	cervix:	n/a	chr20:25990394-25990403
29	BRCA1	chr20:25848519-25848534	GM12878	blood:	n/a	n/a
30	CBX3	chr20:25843839-25844188	K562	blood:	n/a	n/a
31	CBX3	chr20:25834554-25834916	K562	blood:	n/a	n/a
32	CCNT2	chr20:25843881-25844128	K562	blood:	n/a	n/a
33	CEBPB	chr20:25988884-25989639	Hela-S3	cervix:	n/a	chr20:25989469-25989480 chr20:25989451-25989462
34	CEBPB	chr20:25989327-25989510	HepG2	liver:	n/a	chr20:25989469-25989480 chr20:25989451-25989462
35	CEBPB	chr20:25989347-25989484	HepG2	liver:	n/a	chr20:25989469-25989480 chr20:25989451-25989462
36	CEBPB	chr20:25844508-25844516	HepG2	liver:	n/a	n/a
37	CEBPB	chr20:25878573-25878789	IMR90	lung:	n/a	chr20:25878716-25878728 chr20:25878662-25878673
38	CEBPB	chr20:25976255-25976322	HepG2	liver:	n/a	chr20:25976304-25976315
39	CEBPB	chr20:25843063-25843150	K562	blood:	n/a	n/a
40	CEBPB	chr20:25942443-25942488	A549	lung:	n/a	chr20:25942454-25942467 chr20:25942454-25942465
41	CEBPB	chr20:25989323-25989598	H1-hESC	embryonic stem cell:	n/a	chr20:25989469-25989480 chr20:25989451-25989462
42	CEBPB	chr20:25846248-25846410	HepG2	liver:	n/a	n/a
43	CEBPB	chr20:25844039-25844135	Hela-S3	cervix:	n/a	n/a
44	CEBPB	chr20:25878583-25878770	A549	lung:	n/a	chr20:25878716-25878728 chr20:25878662-25878673
45	CEBPB	chr20:25848333-25848714	K562	blood:	n/a	n/a
46	CEBPB	chr20:25849580-25849737	HepG2	liver:	n/a	n/a
47	CEBPB	chr20:25933076-25933229	HepG2	liver:	n/a	chr20:25933144-25933155
48	CEBPB	chr20:25989351-25989594	K562	blood:	n/a	chr20:25989469-25989480 chr20:25989451-25989462
49	CEBPB	chr20:25878611-25878724	K562	blood:	n/a	chr20:25878662-25878673
50	CEBPB	chr20:25843604-25843807	K562	blood:	n/a	n/a

(count:672 , 50 per page) page: 1 2 3 4 5 6 7 ... 14

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr20:25988587-25988637	HIPEpiC	eye:	n/a
2	chr20:25988587-25988637	HIPEpiC	eye:	n/a
3	chr20:25990680-25990730	NT2-D1	testis:	n/a
4	chr20:25988266-25988316	NB4	blood:	n/a
5	chr20:25848969-25849019	BJ	skin:	n/a
6	chr20:25990680-25990730	SK-N-SH_RA	brain:	n/a
7	chr20:25846519-25846569	ProgFib	skin:	n/a
8	chr20:25989775-25989825	Hela-S3	cervix:	n/a
9	chr20:25848969-25849019	GM12878	blood:	n/a
10	chr20:25989674-25989724	AG10803	skin:	n/a
11	chr20:25988587-25988637	Jurkat	blood:	n/a
12	chr20:25848886-25848936	HCM	heart:	n/a
13	chr20:25848886-25848936	T-47D	breast:	n/a
14	chr20:25989032-25989082	IMR90	lung:	fetal
15	chr20:25848969-25849019	GM19239	blood:	n/a
16	chr20:25989032-25989082	H1-hESC	embryonic stem cell:	embryo
17	chr20:25990680-25990730	HAEpiC	amniotic membrane:	n/a
18	chr20:25848886-25848936	SK-N-SH	brain:	n/a
19	chr20:25991114-25991164	Hepatocyte	liver:	n/a
20	chr20:25990680-25990730	SAEC	small airway:	n/a
21	chr20:25988587-25988637	GM06990	blood:	n/a
22	chr20:25989775-25989825	AoSMC	blood vessel:	n/a
23	chr20:25988587-25988637	HPAEpiC	pulmonary alveolar:	n/a
24	chr20:25988587-25988637	A549	lung:	n/a
25	chr20:25990680-25990730	GM12878	blood:	n/a
26	chr20:25990680-25990730	K562	blood:	n/a
27	chr20:25991114-25991164	SK-N-SH_RA	brain:	n/a
28	chr20:25846519-25846569	CMK	blood:	n/a
29	chr20:25988266-25988316	HRE	kidney:	n/a
30	chr20:25834845-25834895	HMEC	breast:	n/a
31	chr20:25834845-25834895	HL-60	blood:	n/a
32	chr20:25989775-25989825	AG09309	skin:	n/a
33	chr20:25988266-25988316	HEK293	kidney:	embryo
34	chr20:25988266-25988316	HPAEpiC	pulmonary alveolar:	n/a
35	chr20:25989775-25989825	NB4	blood:	n/a
36	chr20:25989032-25989082	HEK293	kidney:	embryo
37	chr20:25848969-25849019	HUVEC	blood vessel:	n/a
38	chr20:25989775-25989825	ovcar-3	ovarian:	n/a
39	chr20:25846519-25846569	BE2_C	brain:	n/a
40	chr20:25988587-25988637	RPTEC	kidney:	n/a
41	chr20:25989775-25989825	Hepatocyte	liver:	n/a
42	chr20:25848886-25848936	NHBE	bronchial:	n/a
43	chr20:25848969-25849019	SKMC	muscle:	n/a
44	chr20:25988587-25988637	IMR90	lung:	fetal
45	chr20:25848886-25848936	HEK293	kidney:	embryo
46	chr20:25834845-25834895	HRPEpiC	eye:	n/a
47	chr20:25990680-25990730	HRCEpiC	kidney:	n/a
48	chr20:25989775-25989825	U87	brain:	n/a
49	chr20:25988266-25988316	CMK	blood:	n/a
50	chr20:25848886-25848936	HAEpiC	amniotic membrane:	n/a

(count:1 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr20:25604447..25606097-chr20:25837225..25840203,2	MCF-7	breast:

(count:29 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-FAM182B-3	chr20:25989427-25989691	XLOC_013712
2	lnc-FAM182A-6	chr20:25997553-25997840	ucscGeneNc_uc010gdq_1
3	lnc-FAM182A-6	chr20:25983291-25983721	ucscGeneNc_uc010gdq_1
4	lnc-FAM182A-6	chr20:25999468-25999548	NONHSAT147161
5	lnc-FAM182A-1	chr20:25936722-25936846	ENSG00000226203
6	lnc-FAM182A-1	chr20:25945639-25949924	ENSG00000226203
7	lnc-FAM182A-8	chr20:25893639-25897924	NONHSAT079201
8	lnc-FAM182A-6	chr20:26002406-26002505	ucscGeneNc_uc010gdq_1
9	lnc-FAM182A-8	chr20:25891698-25891832	NONHSAT079201
10	lnc-FAM182A-1	chr20:25943698-25943832	ENSG00000226203
11	lnc-FAM182A-1	chr20:25943698-25943832	XLOC_013502
12	lnc-FAM182B-10	chr20:25930172-25930528	NONHSAT079203
13	lnc-FAM182B-11	chr20:25938891-25939167	NONHSAT079205
14	lnc-FAM182B-2	chr20:25982172-25982528	XLOC_013711
15	lnc-FAM182A-6	chr20:25968084-25968225	NONHSAT079206
16	lnc-FAM182B-10	chr20:25930850-25930935	NONHSAT079203
17	lnc-FAM182A-6	chr20:25999712-25999838	NONHSAT147161
18	lnc-FAM182B-2	chr20:25982850-25982935	XLOC_013711
19	lnc-FAM182A-1	chr20:25936448-25936505	ENSG00000226203
20	lnc-FAM182A-8	chr20:25884448-25884505	NONHSAT079201
21	lnc-FAM182B-11	chr20:25937427-25937691	NONHSAT079205
22	lnc-FAM182B-3	chr20:25990891-25991167	XLOC_013712
23	lnc-FAM182A-6	chr20:26000465-26000560	NONHSAT147161
24	lnc-FAM182A-1	chr20:25936722-25936846	XLOC_013502
25	lnc-FAM182A-1	chr20:25936453-25936505	XLOC_013502
26	lnc-FAM182A-8	chr20:25884722-25884846	NONHSAT079201
27	lnc-FAM182A-6	chr20:26001272-26001320	NONHSAT147161
28	lnc-FAM182A-6	chr20:25990334-25991091	NONHSAT079206
29	lnc-FAM182A-1	chr20:25945639-25949923	XLOC_013502

No data

Variant related genes	Relation type
FAM182B	TF binding region
CFTRP1	TF binding region
ENSG00000231081	TF binding region
ENSG00000204556	TF binding region
ENSG00000226203	TF binding region
FAM182B	CpG island
CFTRP1	CpG island
ENSG00000231081	CpG island
ENSG00000204556	CpG island
ENSG00000226203	CpG island
ENSG00000213742	chromatin interactions
ENSG00000170191	chromatin interactions
MUC17	miRNA target sites
LIMCH1	miRNA target sites

Extended variants
information (count: 4396 )
Associated
traits (count: 47 )

Variant overlapped rSNPs/rCNVs (count:4396 , 50 per page) page: 1 2 3 4 5 6 7 ... 88

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs74701733	chr20:25832117-25832118	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
2	rs78918351	chr20:25832119-25832120	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
3	rs76854235	chr20:25832141-25832142	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
4	rs531715451	chr20:25832155-25832156	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
5	rs77393953	chr20:25832176-25832177	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
6	rs537150064	chr20:25832183-25832184	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
7	rs6050929	chr20:25832184-25832185	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
8	rs111754517	chr20:25832200-25832201	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
9	rs571961203	chr20:25832204-25832205	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
10	rs114265444	chr20:25832227-25832228	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
11	rs6115327	chr20:25832239-25832240	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
12	rs146239699	chr20:25832255-25832256	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
13	rs6115328	chr20:25832264-25832265	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
14	rs368611451	chr20:25832271-25832272	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
15	rs573766791	chr20:25832287-25832288	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
16	rs371203490	chr20:25832294-25832295	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
17	rs6115329	chr20:25832306-25832307	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
18	rs201222773	chr20:25832314-25832315	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
19	rs147798010	chr20:25832316-25832317	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
20	rs552880068	chr20:25832343-25832344	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
21	rs572490829	chr20:25832355-25832356	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
22	rs184582532	chr20:25832357-25832358	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
23	rs73348924	chr20:25832364-25832365	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
24	rs76027448	chr20:25832389-25832390	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
25	rs149842246	chr20:25832420-25832421	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
26	rs564636818	chr20:25832421-25832422	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
27	rs73348925	chr20:25832433-25832434	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
28	rs35939156	chr20:25832447-25832448	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
29	rs398035549	chr20:25832448-25832449	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
30	rs73348930	chr20:25832468-25832469	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
31	rs79005963	chr20:25832481-25832482	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
32	rs575254411	chr20:25832482-25832483	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
33	rs543982242	chr20:25832508-25832509	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
34	rs374243013	chr20:25832517-25832518	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
35	rs113185743	chr20:25832525-25832526	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
36	rs189102828	chr20:25832545-25832546	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
37	rs6050930	chr20:25832577-25832578	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
38	rs6083962	chr20:25832579-25832580	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
39	rs376900939	chr20:25832582-25832583	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
40	rs371411946	chr20:25832590-25832591	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
41	rs374677094	chr20:25832593-25832594	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
42	rs6083963	chr20:25832617-25832618	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
43	rs193290575	chr20:25832630-25832631	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
44	rs11696651	chr20:25832653-25832654	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
45	rs368967515	chr20:25832675-25832676	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
46	rs373267801	chr20:25832682-25832683	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
47	rs367798572	chr20:25832714-25832715	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
48	rs6050931	chr20:25832731-25832732	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
49	rs185532636	chr20:25832734-25832735	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
50	rs143987133	chr20:25832735-25832736	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:47)

Disease	PMID	Source
Cancer	21637783	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Ewing''s sarcoma	21437220	CNVD
Oral cancer	19627613	CNVD
colon cancer	17210682	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	21080181	CNVD
Thyroid cancer	19087340	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Cancer	16751803	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Colorectal cancer	19359472	CNVD
Esophageal squamous carcinoma	18350619	CNVD
Human rectal carcinomas	16397240	CNVD
Olfactory neuroblastoma	18408657	CNVD
Central neurocytomas	17123091	CNVD
Colorectal cancer	16272173	CNVD
Medulloblastoma	21979893	CNVD
Gastric cancer	17908304	CNVD
Urothelial carcinoma	21177765	CNVD
Acute myeloid leukemia	20729466	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Ewing''s sarcoma	17952124	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Colorectal cancer	21645411	CNVD
Lung cancer	18438408	CNVD
Autism	22495311	CNVD
Anaplastic large cell lymphoma	18179710	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Cancer	21183584	CNVD
Myxofibrosarcoma	16751306	CNVD
Pancreatic endocrine tumor	17639061	CNVD
Bladder cancer	21909424	CNVD
Esophageal cancer	21851588	CNVD
Chordoma	18071362	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Breast cancer	21364760	CNVD
small cell lung cancer	20016488	CNVD
Colorectal cancer	16774939	CNVD
Non-syndromic sensorineural hearing loss	17122850	CNVD
Non-syndromic sensorineural hearing loss	21293372	CNVD
Breast cancer	22522925	CNVD
Non-syndromic sensorineural hearing loss	21030649	CNVD

Chromatin state (count:2356 , 50 per page) page: 1 2 3 4 5 6 7 ... 48

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr20:25826000-25832200	Weak transcription	Breast Myoepithelial Primary Cells	Breast
2	chr20:25826000-25833200	Weak transcription	Duodenum Smooth Muscle	Duodenum
3	chr20:25826000-25833600	Weak transcription	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
4	chr20:25826000-25833800	Weak transcription	Aorta	Aorta
5	chr20:25826000-25833800	Weak transcription	HSMMtube	muscle
6	chr20:25826200-25832600	Weak transcription	Skeletal Muscle Female	skeletal muscle
7	chr20:25826200-25833600	Weak transcription	Brain Anterior Caudate	brain
8	chr20:25826200-25833600	Weak transcription	Brain Dorsolateral Prefrontal Cortex	brain
9	chr20:25826200-25833600	Weak transcription	Brain Substantia Nigra	brain
10	chr20:25826200-25833600	Weak transcription	Right Ventricle	heart
11	chr20:25828400-25833600	Weak transcription	Left Ventricle	heart
12	chr20:25829400-25833600	Weak transcription	Brain Cingulate Gyrus	brain
13	chr20:25829400-25833600	Weak transcription	Brain Hippocampus Middle	brain
14	chr20:25829400-25833600	Weak transcription	Colonic Mucosa	Colon
15	chr20:25829400-25833600	Weak transcription	Esophagus	oesophagus
16	chr20:25829400-25833600	Weak transcription	Fetal Lung	lung
17	chr20:25829400-25833600	Weak transcription	Ovary	ovary
18	chr20:25829400-25834200	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
19	chr20:25829400-25836200	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
20	chr20:25829600-25833600	Weak transcription	Brain Angular Gyrus	brain
21	chr20:25829600-25833600	Weak transcription	Pancreas	Pancrea
22	chr20:25829600-25833600	Weak transcription	Spleen	Spleen
23	chr20:25829800-25833600	Weak transcription	Brain Inferior Temporal Lobe	brain
24	chr20:25829800-25833600	Weak transcription	Fetal Muscle Leg	muscle
25	chr20:25829800-25833600	Weak transcription	Lung	lung
26	chr20:25829800-25833600	Weak transcription	Stomach Smooth Muscle	stomach
27	chr20:25830600-25833600	Weak transcription	Fetal Stomach	stomach
28	chr20:25831000-25833400	Weak transcription	HepG2	liver
29	chr20:25831000-25833800	Weak transcription	Gastric	stomach
30	chr20:25831200-25833600	Weak transcription	Foreskin Melanocyte Primary Cells skin03	Skin
31	chr20:25831200-25833800	Weak transcription	Fetal Adrenal Gland	Adrenal Gland
32	chr20:25832000-25832600	Enhancers	Dnd41	blood
33	chr20:25832200-25832400	Bivalent Enhancer	Primary T cells fromperipheralblood	blood
34	chr20:25832200-25833400	Enhancers	Breast Myoepithelial Primary Cells	Breast
35	chr20:25832600-25833600	Enhancers	Skeletal Muscle Female	skeletal muscle
36	chr20:25832600-25834000	Flanking Active TSS	Dnd41	blood
37	chr20:25832800-25834200	Enhancers	Fetal Brain Male	brain
38	chr20:25833200-25835400	Active TSS	Duodenum Smooth Muscle	Duodenum
39	chr20:25833400-25833600	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
40	chr20:25833400-25833600	Enhancers	Adipose Nuclei	Adipose
41	chr20:25833400-25833600	Enhancers	Duodenum Mucosa	Duodenum
42	chr20:25833400-25833600	Enhancers	HepG2	liver
43	chr20:25833400-25835000	Active TSS	Breast Myoepithelial Primary Cells	Breast
44	chr20:25833400-25835200	Active TSS	Pancreatic Islets	Pancreatic Islet
45	chr20:25833600-25833800	Active TSS	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
46	chr20:25833600-25833800	Bivalent Enhancer	Primary T cells fromperipheralblood	blood
47	chr20:25833600-25833800	Enhancers	Primary T helper naive cells fromperipheralblood	blood
48	chr20:25833600-25833800	Enhancers	Primary T helper cells PMA-I stimulated	--
49	chr20:25833600-25833800	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
50	chr20:25833600-25833800	Enhancers	Foreskin Melanocyte Primary Cells skin01	Skin

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links